-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The China Pharmaceutical Industry Information Center has screened 29 drugs whose patents will expire in 2022 through the new drug development monitoring database (CPM).
Table 1: 2025 Market Scale Forecast for Expired Drugs by Therapeutic Area/Generic Name
Source: Cortellis, organized by China Pharmaceutical Industry Information Center
The following is a sample hospital drug market performance of the six potential therapeutic areas of digestive system drugs, nervous system drugs, endocrine and metabolic regulation drugs, mental disorder drugs, urinary system drugs, and anti-tumor drugs, and the key indications in these fields.
Market Performance of Sample Hospital Drugs in Potential Treatment Areas
Market Performance of Sample Hospital Drugs in Potential Treatment AreasPotential therapeutic area 1: Digestive system drugs
Potential therapeutic area 1: Digestive system drugsJudging from the sales data of the national sample hospital drug market, the sales amount of digestive system drug sample hospitals in 2021 will be 19.
Judging from the sales data of the national sample hospital drug market, the sales amount of digestive system drug sample hospitals in 2021 will be 19.
Source: Drug Comprehensive Database (PDB), China Pharmaceutical Industry Information Center
Potential therapeutic area 2: Nervous system drugs
Potential therapeutic area 2: Nervous system drugsJudging from the sales data of the national sample hospital drug market, the sales amount of the nervous system drug sample hospital in 2021 is 17.
Judging from the sales data of the national sample hospital drug market, the sales amount of the nervous system drug sample hospital in 2021 is 17.
Source: Drug Comprehensive Database (PDB), China Pharmaceutical Industry Information Center
Potential therapeutic area 3: endocrine and metabolic regulation drugs
Potential therapeutic area 3: endocrine and metabolic regulation drugsJudging from the sales data of the national sample hospital drug market, the sales amount of endocrine and metabolic regulation drugs in the sample hospital in 2021 will be 15.
Judging from the sales data of the national sample hospital drug market, the sales amount of endocrine and metabolic regulation drugs in the sample hospital in 2021 will be 15.
Source: Drug Comprehensive Database (PDB), China Pharmaceutical Industry Information Center
Potential therapeutic area 4: Drugs for mental disorders
Potential therapeutic area 4: Drugs for mental disordersJudging from the sales data of the national sample hospital drug market, the sales amount of mental disorder drugs in the sample hospital in 2021 will be 5.
Judging from the sales data of the national sample hospital drug market, the sales amount of mental disorder drugs in the sample hospital in 2021 will be 5.
Source: Drug Comprehensive Database (PDB), China Pharmaceutical Industry Information Center
Potential therapeutic area 5: Urinary system drugs
Potential therapeutic area 5: Urinary system drugsJudging from the sales data of the drug market in sample hospitals across the country, the sales amount of urology drugs in the sample hospitals in 2021 is 940 million yuan, and the peak sales amount in 2019 reached 1.
Judging from the sales data of the drug market in sample hospitals across the country, the sales amount of urology drugs in the sample hospitals in 2021 is 940 million yuan, and the peak sales amount in 2019 reached 1.
Source: Drug Comprehensive Database (PDB), China Pharmaceutical Industry Information Center
Potential therapeutic area 6: Antineoplastic drugs
Potential therapeutic area 6: Antineoplastic drugsJudging from the sales data of the national sample hospital drug market, the sales amount of antitumor drugs in the sample hospitals in 2021 will be 40.
Judging from the sales data of the national sample hospital drug market, the sales amount of antitumor drugs in the sample hospitals in 2021 will be 40.
Source: Drug Comprehensive Database (PDB), China Pharmaceutical Industry Information Center
Distribution of popular research targets for key indications
Distribution of popular research targets for key indicationsNote: The data in this section are all from the Intelligent Drug Big Data Analysis Platform (PharmaONE) database of China Pharmaceutical Industry Information Center
Key indication 1: biliary atresia, cholestasis
Key indication 1: biliary atresia, cholestasisFigure 7: Global drugs for biliary atresia and cholestasis involve a total of 71 targets - TOP10 targets
Figure 8: 13 targets are involved in Chinese drugs for biliary atresia and cholestasis - TOP10 targets
Key indication 2: Epilepsy
Key indication 2: EpilepsyFigure 9: A total of 170 targets are involved in global epilepsy drugs - TOP10 targets
Figure 10: Chinese epilepsy drugs involve a total of 38 targets - TOP10 targets
Key Indications 3: Obesity, Diabetes
Key Indications 3: Obesity, DiabetesFigure 11: A total of 754 targets are involved in global drugs for obesity and diabetes - TOP10 targets
Figure 12: Obesity, diabetes Chinese drugs involve a total of 141 targets - TOP10 targets
Key indication four: schizophrenia
Key indication four: schizophreniaFigure 13: Global drugs for schizophrenia involve a total of 230 targets - TOP10 targets
Figure 14: Chinese medicines for schizophrenia involve a total of 52 targets - TOP10 targets
Key indication five: urinary incontinence, overactive bladder
Key indication five: urinary incontinence, overactive bladderFigure 15: Global drugs for urinary incontinence and overactive bladder involve a total of 94 targets - TOP10 targets
Figure 16: Chinese drugs for urinary incontinence and overactive bladder involve a total of 15 targets - TOP10 targets
Key indication 6: liver cancer, colorectal tumor, non-small cell lung cancer, solid tumor, brain cancer
Key indication 6: liver cancer, colorectal tumor, non-small cell lung cancer, solid tumor, brain cancerFigure 17: Pan-cancer solid tumor global drugs involve a total of 114 targets - TOP10 targets
Figure 18: Pan-cancer solid tumor Chinese drugs involve a total of 37 targets - TOP10 targets
